A bipartisan group of U.S. senators wrote a letter to the Federal Trade Commission in January requesting an update on its ongoing investigation of pharmacy benefit managers.

"We support the FTC's issuance of a Section 6(b) order and conducting a timely study of PBMs' business practices," said the letter from Sen. Chuck Grassley, R-Iowa, Sen. Maria Cantwell, D-Wash., and 12 colleagues. "With the FTC's inquiry reaching its year-and-a-half mark, we urge the FTC to complete the study without delay. In the interim, we believe it is important to know the status of the study and therefore ask the FTC to issue a progress report."

Complete your profile to continue reading and get FREE access to BenefitsPRO, part of your ALM digital membership.

Your access to unlimited BenefitsPRO content isn’t changing.
Once you are an ALM digital member, you’ll receive:

  • Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
  • Educational webcasts, white papers, and ebooks from industry thought leaders
  • Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Consumer Driven Health Care
Core and Group Health
Health Care Reform
Employee Participation
Employee-Paid
Employer-Paid